Egis Pharmaceuticals Plc. has acquired one of Teva Pharmaceuticals Plc.'s well-known product family for skin application, following the approval of the competition authority, the pharmaceutical manufacturer informed MTI on Monday. According to the statement, the takeover of the distribution and promotion of the product line began on December 17, 2024, and the parties sought to […]
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.